『​​Patently Strategic - Patent Strategy for Startups』のカバーアート

​​Patently Strategic - Patent Strategy for Startups

​​Patently Strategic - Patent Strategy for Startups

著者: Aurora Patent Consulting | Ashley Sloat Ph.D.
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり
A patent focused podcast for inventors, founders, and IP professionals, covering the finer points, sharp edges, and nuances of startup patent strategy. Each monthly episode will feature a round-table style discussion amongst experts in the field of patenting. Patently Strategic is brought to you by Aurora Consulting, a patent strategy boutique that specializes in working with early stage life science, medical​ device, digital health, and software companies to develop valuable patent portfolios through highly tailored, comprehensive strategies.© 2026 Aurora Consulting LLC 科学 経済学
エピソード
  • Prompting and Patents: What to Know Before You Ask AI
    2026/10/01

    AI can now produce something that very much *looks* like a patent application. It can be long. It can be technical. It can have claims. It can use many of the right-sounding words in approximately the right-sounding places. But does it actually protect your invention? And that distinction—between something that looks impressive and something that creates a durable legal asset — is everything to an inventor hoping to reliably protect their innovation. From a subtle word-choice mistake to a major hallucination, even the smallest details can lead to unintended, fatal consequences for intellectual property rights. And as anyone who uses AI regularly knows, the dangerous part is when it gives you output that is 90 percent convincing. AI can be extraordinarily persuasive while being extraordinarily wrong.

    Over this past year, our firm has seen a major uptick in inventor use of AI to brainstorm ideas, organize invention disclosures, search for prior art, analyze office actions, and—in some cases—draft entire patent applications. And why wouldn’t the pioneers and professionals at the forefront of science and technology be using every tool at their disposal for technological and economic advantage? We strongly believe that for both practitioners and inventors, AI offers many compelling, cost-effective uses that should culminate in more robust IP rights. But like with many things at the intersection of technology and law, absolutes are perilous, and the devil hides in the details.

    ** Episode Overview **

    To help cut through the uncertainty and get to the most effective and responsible use of AI possible, Dr. Ashley Sloat, leads a discussion with a panel of expert patent practitioners exploring where AI is genuinely helping in patent drafting and prosecution, where they’re seeing it go wrong, the surprising ways it can actually increase legal costs, what recent court decisions may mean for confidential information, and some practical guardrails for inventors who want the benefits of AI without inadvertently undermining the very intellectual property they’re trying to protect.

    ** Mossoff Minute: USPTO Report on Impact of IP-intensive industries **

    In this month's Mossoff Minute, Professor Adam Mossoff discusses a report recently published by the USPTO with data that highlights the importance and impact of IP-intensive industries on the US economy.

    ** Links Mentioned **

    ⦿ Patent Docketing Specialist job application: https://www.aurorapatents.com/careers-patent-docketing-specialist.html
    ⦿ Generative AI Tools for Patent Drafting white paper: https://www.reuters.com/practical-law-the-journal/transactional/evaluating-generative-ai-tools-patent-drafting-2026-03-01/
    ⦿ Aurora's client FAQ for using AI for patent drafting and prosecution: https://www.aurorapatents.com/client-use-of-ai-faq.html.

    ** Follow Aurora Patents **

    ⦿ Home: https://www.aurorapatents.com/
    ⦿ Twitter: https://twitter.com/AuroraPatents
    ⦿ LinkedIn: https://www.linkedin.com/company/aurora-cg/
    ⦿ Facebook: https://www.facebook.com/aurorapatents/
    ⦿ Instagram: https://www.instagram.com/aurorapatents/
    ⦿ TikTok: https://www.tiktok.com/@aurorapatents
    ⦿ YouTube: https://www.youtube.com/@aurorapatents/

    Let us know what you think about this episode!

    続きを読む 一部表示
    1 時間 1 分
  • The Biotech Bargain: How Patents Help Turn Risk Into Medicine
    2026/07/03
    Do patents make drugs more expensive? And what role does intellectual property play in getting new medicines from the lab bench to patients?The questions have never been more timely. Biopharmaceutical innovation sits at the center of some of our biggest public policy debates. Drug pricing, access, generic competition, university research, venture funding, AI-driven discovery, follow-on research, and the future of biotech startups. And in the middle of those debates, patents are often reduced to slogans like patent monopolies and ever-greening and are assigned the political blame for high drug prices and limited patient access to medical breakthroughs. But the real system is much more complicated. Modern drug development is extraordinarily expensive, uncertain, regulated, and risky. A promising discovery may begin in a university lab, move through a startup, require venture financing, depend on partnerships with larger pharmaceutical companies, survive years of clinical testing, and then still face manufacturing approval, reimbursement, safety monitoring, and market adoption hurdles.Along that path, intellectual property is not just a prize at the end. It can be the asset that allows investment, collaboration, disclosure, licensing, specialization, and commercialization to happen in the first place. At the same time, the public has a legitimate interest in access, affordability, competition, and generic entry. So the policy challenge is understanding how the system works, what incentives are actually doing, and what can go wrong when lawmakers, courts, and pundits oversimplify the trade-offs.This is a big conversation, but the through line is simple. If we want more medicines, better medicines, and broader access to medicines, we need to understand the innovation system clearly before we start rewriting the rules.** Special Guest: Dr. Bo Heiden ** To help us truly understand the critical role of patent protections in the biopharmaceutical ecosystem and what prevailing narratives mean for investors, startups, and biotech R&D, we’re sitting down with Dr. Bo Heiden, one of the leading thinkers working at the intersection of intellectual property, innovation strategy, and life sciences policy. Dr. Heiden is the co-director of the Eira Initiative, a project out of the Berkeley Policy Institute, the Executive Director for the Tusher Strategic Initiative for Technology Leadership at Berkeley’s Haas School of Business, the Co-Director of the Center for Intellectual Property (CIP) at University of Gothenburg, and the Co-Chair of the Technology, Innovation, and Intellectual Property program at the Classical Liberal Institute at the NYU School of Law.** Episode Overview **⦿ Drug price and access concerns, as they pertain to patents.⦿ The economic realities that make drug development a uniquely risky investment problem.⦿ The CliffsNotes history of why the modern biotech system emerged so strongly in the United States.⦿ What policymakers often miss in narratives around evergreening and patent monopolies, and how those narratives may now be pushing policy in directions that could undermine the very startup and R&D ecosystem we all depend on for advancements in medicine.⦿ The Supreme Court’s recent Hikma decision and what it means for skinny labels, induced infringement, and generic competition. ⦿ Practical takeaways on two of the hottest areas in the market: AI-driven drug discovery and the evolving GLP-1 regulatory and generic landscape.** Mossoff Minute: America's 250th and the Democratization of Invention **In this month's Mossoff Minute, Professor Adam Mossoff discusses the democratization of invention sparked by American independence.** Follow Aurora Patents **⦿ Home: https://www.aurorapatents.com/⦿ Twitter: https://twitter.com/AuroraPatents⦿ LinkedIn: https://www.linkedin.com/company/aurora-cg/⦿ Facebook: https://www.facebook.com/aurorapatents/⦿ Instagram: https://www.instagram.com/aurorapatents/ ⦿ TikTok: https://www.tiktok.com/@aurorapatents⦿ YouTube: https://www.youtube.com/@aurorapatents/Let us know what you think about this episode!
    続きを読む 一部表示
    1 時間 1 分
  • Design Patents: Building Better Moats
    2026/04/27

    When most people think or speak generally about patents, they’re really talking about utility patents – or patents that are primarily concerned with how an invention is used and how it works. But as it turns out, this is just one specific type of patent on the complete menu of options available for protecting your innovations. Another option, called a design patent, exists to – additionally or alternatively – protect the appearance of your invention.

    And whether you find yourself in an either/or or a both situation, it’s important to consider all tools at your disposal in covering every uniquely protectable functional and visual aspect of your inventions. This is often referred to as building a moat around your business. In this month’s IP Market Insights Newsletter, former guest of the podcast, Louis Carbonneau, wrote that:

    "Morningstar’s research has consistently shown that companies with wide economic moats — those with defensible advantages expected to last 20 years or more — dramatically outperform those without. When Buffett said he looks for 'economic castles protected by unbreachable moats,' he wasn’t being quaint".

    ** Episode Overview **

    Design patents play a critical role in your broader portfolio and in making your moat as wide and unbreachable as possible. This is why we’ve enlisted the help of our very own Dr. Tiffany Miller to guide us through all of the do’s and don’ts. As you’ll hear today, Tiffany has some very unique and practical insights into how even the most nuanced aspects of design patents can significantly impact infringement cases.

    ⦿ The definition, term, and features of design patents.
    ⦿ How design patents compare with utility patents.
    ⦿ Obviousness implications for the patent office and the courts – including what to possibly make of the courts wiping the case law slate clean on design patent obviousness back in 2025.
    ⦿ And some really great interactive panel discussions around real-world design patent examples and how courts have weighed in on patentability.

    ** Mossoff Minute: Loss of American Leadership **

    In this month's Mossoff Minute, Professor Adam Mossoff discusses the unfortunate loss of American leadership on the international stage in terms of defending the fundamental rights and rules for how we protect patents.

    ** Follow Aurora Patents **

    ⦿ Home: https://www.aurorapatents.com/
    ⦿ Twitter: https://twitter.com/AuroraPatents
    ⦿ LinkedIn: https://www.linkedin.com/company/aurora-cg/
    ⦿ Facebook: https://www.facebook.com/aurorapatents/
    ⦿ Instagram: https://www.instagram.com/aurorapatents/
    ⦿ TikTok: https://www.tiktok.com/@aurorapatents
    ⦿ YouTube: https://www.youtube.com/@aurorapatents/

    Let us know what you think about this episode!

    続きを読む 一部表示
    56 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません